To validate the hypothesis that the protein signature comprising CRYM, PFKL, CAPZA, ALDH16A1, SERPINC1, and HP can distinguish ALS from control subjects, we quantified these six proteins using Western blots in an independent validation cohort (Fig. 3a). The gene discussed is SERPINC1; the disease is amyotrophic lateral sclerosis.